Buchholz U - Search Results

1

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.

Englund JA, Karron RA, Cunningham CK, Larussa P, Melvin A, Yogev R, Handelsman E, Siberry GK, Thumar B, Schappell E, Bull CV, Chu HY, Schaap-Nutt A, Buchholz U, Collins PL, Schmidt AC; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1096 Study Group. Englund JA, et al. Among authors: buchholz u. Vaccine. 2013 Nov 19;31(48):5706-12. doi: 10.1016/j.vaccine.2013.09.046. Epub 2013 Oct 5. Vaccine. 2013. PMID: 24103895 Free PMC article. Clinical Trial.

2

Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.

Buchholz UJ, Granzow H, Schuldt K, Whitehead SS, Murphy BR, Collins PL. Buchholz UJ, et al. J Virol. 2000 Feb;74(3):1187-99. doi: 10.1128/jvi.74.3.1187-1199.2000. J Virol. 2000. PMID: 10627529 Free PMC article.

3

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.

Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, Collins PL. Buchholz UJ, et al. Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9. doi: 10.1073/pnas.0403492101. Epub 2004 Jun 21. Proc Natl Acad Sci U S A. 2004. PMID: 15210961 Free PMC article.

4

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St Claire M, Murphy BR, Subbarao K, Collins PL. Bukreyev A, et al. Lancet. 2004 Jun 26;363(9427):2122-7. doi: 10.1016/S0140-6736(04)16501-X. Lancet. 2004. PMID: 15220033 Free PMC article.

5

Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate.

Biacchesi S, Skiadopoulos MH, Yang L, Lamirande EW, Tran KC, Murphy BR, Collins PL, Buchholz UJ. Biacchesi S, et al. J Virol. 2004 Dec;78(23):12877-87. doi: 10.1128/JVI.78.23.12877-12887.2004. J Virol. 2004. PMID: 15542640 Free PMC article.

H. Skiadopoulos, K. C. Tran, B. R. Murphy, P. L. Collins, and U. J. Buchholz, Virology 321:247-259, 2004) was used to generate recombinant HMPVs (rHMPVs) that lack the G gene, the SH gene, or both. ...

H. Skiadopoulos, K. C. Tran, B. R. Murphy, P. L. Collins, and U. J. Buchholz, Virology 321:247-259, 2004) was used to generate …

6

Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates.

Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. Biacchesi S, et al. J Virol. 2005 Oct;79(19):12608-13. doi: 10.1128/JVI.79.19.12608-12613.2005. J Virol. 2005. PMID: 16160190 Free PMC article.

7

Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity.

Skiadopoulos MH, Biacchesi S, Buchholz UJ, Amaro-Carambot E, Surman SR, Collins PL, Murphy BR. Skiadopoulos MH, et al. Virology. 2006 Feb 20;345(2):492-501. doi: 10.1016/j.virol.2005.10.016. Epub 2005 Nov 21. Virology. 2006. PMID: 16300813 Free article.

8

Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo.

Pham QN, Biacchesi S, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. Pham QN, et al. J Virol. 2005 Dec;79(24):15114-22. doi: 10.1128/JVI.79.24.15114-15122.2005. J Virol. 2005. PMID: 16306583 Free PMC article.

9

Live vaccines for human metapneumovirus designed by reverse genetics.

Buchholz UJ, Nagashima K, Murphy BR, Collins PL. Buchholz UJ, et al. Expert Rev Vaccines. 2006 Oct;5(5):695-706. doi: 10.1586/14760584.5.5.695. Expert Rev Vaccines. 2006. PMID: 17181442 Review.

10

Frequent frameshift and point mutations in the SH gene of human metapneumovirus passaged in vitro.

Biacchesi S, Murphy BR, Collins PL, Buchholz UJ. Biacchesi S, et al. J Virol. 2007 Jun;81(11):6057-67. doi: 10.1128/JVI.00128-07. Epub 2007 Mar 21. J Virol. 2007. PMID: 17376897 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page